Funded Tech Companies
AlgoTx
AlgoTx is a healthcare services growth company, based in Suresnes. VC investment came from OMNES Capital, InnoBio Fund and Bpifrance.
Company Overview
Company Name
AlgoTx
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
49 rue des Nouvelles
Suresnes, 92150
FR
Suresnes, 92150
FR
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
At AlgoTx we develop novel solutions to relieve patients with difficult-to-treat « Complex Pain. We do so by prioritizing indications that have no proven and approved therapy, and tailoring treatment to the very specific needs of the affected patients. FDA aprouved ATX01's entry into Phase 2 in Chemotherapy-Induced Peripheral Neuropathy. In parallel, we are exploring its potential in a rare and painful disease, erythromelalgia. ATX01's topical administration enables the direct blockade of pain messaging in the nerve fibers of the skin, and limits the systemic side-effects potential associated with oral or intravenous drugs.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/15/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stéphane Thiroloix
Co-Founder
Olivier Bohuon
Company Investors
- OMNES Capital
- InnoBio Fund
- Bpifrance
- UI Investissement
- Turenne
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs